Journal Article

The benefits and limitations of donating new contraceptive technology: The case of the International Contraceptive Access (ICA) Foundation and the LNG IUS Program in Brazil

The International Contraceptive Access (ICA) Foundation was established in Finland in December 2003 as a public–private partnership between Bayer AG, a global pharmaceutical company, and the Population Council, an international nonprofit nongovernmental organization. The objective of the Foundation was to provide public service-delivery organizations with the levonorgestrel 52 mg intrauterine system (LNG IUS) on a not-for-profit basis to serve the reproductive needs of women in resource-poor settings in developing countries.